XLOCK BIOSCIENCES, LLC
Muskego, WI · Biotech · Private
CCL20LD, an engineered recombinant protein therapeutic for psoriatic arthritis
- Grants
- $4.7M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Development of an engineered CCL20 protein as a lead therapeutic molecule for psoriasis | $1,685,879 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of an engineered CCL20 protein as a lead therapeutic molecule for psoriasis | $829,097 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of an engineered CCL20 as a therapeutic molecule for chronic graft-versus-host disease | $259,613 | |
| Federal grant | Department of Health and Human Services · Phase II · Targeting the CCR6-CCL20 pathway for treatment of psoriatic joint and entheseal inflammation | $998,606 | |
| Federal grant | Department of Health and Human Services · Phase II · Targeting the CCR6-CCL20 pathway for treatment of psoriatic joint and entheseal inflammation | $966,201 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1281 | FPRT BIO, INC. | — | — |
| 1282 | ADVANCED VIROLOGY INC. | — | — |
| 1283 | IMMUNE MODULATORY THERAPIES, LLC | — | — |
| 1284 | XLOCK BIOSCIENCES, LLC | — | — |
| 1285 | GENETIC INTELLIGENCE | — | — |
| 1286 | BINARY GENOMICS, INC. | — | — |
| 1287 | ELIXERA, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.